Efficacy and Safety of Sarilumab in COVID-19: A Systematic Review

BACKGROUND: It has been found that there is overactivation of immune response in patients with COVID-19. Several studies are going on to assess the role of immunomodulation. IL-6 antibodies such as tocilizumab have been found to have efficacy in the treatment of COVID-19. We aim to assess the role o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamlagain, Rajan, Shah, Sangam, Sharma Paudel, Basanta, Dhital, Roman, Kandel, Bipin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556127/
https://www.ncbi.nlm.nih.gov/pubmed/34721573
http://dx.doi.org/10.1155/2021/8903435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556127/
https://www.ncbi.nlm.nih.gov/pubmed/34721573
http://dx.doi.org/10.1155/2021/8903435

Ejemplares similares